Apyx Medical Corporation: updates and filings

APYXNASDAQHealthcare · Surgical & Medical Instruments & Apparatus

Price

$2.81

November 13, 2026Market cap $118M

What Ploutos Investor adds for Apyx Medical

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 81 daysAround Feb 5, 2027 · for Q4 2026

last Nov 5, 2026next Feb 5, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Mar 10, 2026 latest annualNov 5, 2026 latest quarterly
  • Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Nov 5, 2026Results of operations
    Form8-K
  • Oct 28, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Sep 29, 2026Other material events
    Form8-K
  • Aug 7, 2026Officer or director change, shareholder vote
    Form8-K
  • Aug 6, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Aug 6, 2026Results of operations
    Form8-K
  • Jul 24, 2026Other material events
    Form8-K
  • Jul 21, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jun 26, 2026Annual meeting proxy statement
    FormDEF 14A
  • Jun 17, 2026Material agreement entered
    Form8-K
  • Jun 1, 2026Conflict minerals report
    FormSD
  • May 21, 2026Other material events
    Form8-K
  • May 14, 2026Other material events
    Form8-K
  • May 11, 2026Other material events
    Form8-K
  • May 7, 2026Quarterly reportfor the period to Mar 31, 2026
    Form10-Q
  • May 7, 2026Results of operations
    Form8-K
  • Mar 10, 2026Annual reportfor the period to Dec 31, 2025
    Form10-K
  • Mar 10, 2026Results of operations
    Form8-K
  • Feb 13, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jan 20, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jan 12, 2026Results of operations
    Form8-K
  • Dec 16, 2025Filing
    FormEFFECT
  • Dec 12, 2025Amended articles or bylaws
    Form8-K
  • Dec 12, 2025Correspondence with the SEC
    FormCORRESP

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Dec 21, 1995.

The full analysis

What do Apyx Medical's filings show?

The filings are where every one of Apyx Medical's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.